HealthDay on MSN
FDA Approves At-Home Version of Lasix for Heart Failure Care
Key Takeaways The U.S. Food and Drug Administration has approved Lasix ONYU, an at-home version of the common heart failure drug LasixThe device allows safe treatment for fluid buildup without ...
Quantum computing has surged into one of the market’s hottest sectors over the past two years. Leading players in the space ...
AVM Biotechnology is commercializing “AVM0703”, a fully developed small‑molecule drug, intended to fight all forms of cancer with a simple one‑hour outpatient infusion designed to re-activate the body ...
The Subject Expert Committee (SEC - Oncology) under the Central Drugs Standard Control Organization (CDSCO) has recommended ...
Iovance Biotherapeutics, Inc. remains a Buy rating due to Amtagvi sales growth and label expansions. Click here to read more ...
Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved ...
The White House budget office said in a court filing that well over 4,000 workers would be dismissed, though it noted that ...
The Trump administration has provided a $300 million infusion to a food aid program for low-income mothers and children, ...
Data from first cohort of five participants suggest an acceptable safety profile for AB-1003 in participants with limb-girdle muscular dystrophy (LGMD) 2I/R9, with no dose-limiting toxicities or ...
With world-class infrastructure and a top-rated talent pipeline, Virginia is reshaping the future of innovation for the ...
A recent study finds that despite biosimilar use rising to 60% to 86% for three cancer drugs, predicted savings don’t match ...
The White House budget office said Friday that mass firings of federal workers have started in an attempt to exert more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results